Security key
92511W207
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)
CUSIP: 92511W207
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 17,313
- Total 13F value
- $106,025
- Share change
- -625
- SEC-reported price per share
- $6.12
- Number of holders
- 6
- Value change
- -$3,825
- Number of buys
- 1
- Number of sells
- 1
- Shares outstanding
- 8,810,762
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
6
Top holders
6
VRCA full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Verrica Pharmaceuticals Inc. SEC filings
Verrica Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92511W207
Recent filing periods:
Ownership snapshot
Top reported holders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Paul B. Manning
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Mar 2026
3/4/5
13D/G
13F
Lead comparable stake: 50%
13D/G row: Paul B. Manning
Showing 1-6 of 15 holder rows.
Quick read
Paul B. Manning leads the comparable SEC ownership view at 50%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Paul B. Manning's linked filing trail.
Comparable ownership
Top 5
Paul B. Manning
50%
Caligan Partners LP
10%
Affinity Asset Advisors, LLC
5.5%
ARMISTICE CAPITAL, LLC
5%
PERCEPTIVE ADVISORS LLC
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Paul B. Manning |
3/4/5
13D/G
Director, 10%+ Owner
|
50%
from 13D/G
|
$32,171,572
31,591,877 shares
mixed-class rows
|
+$17,505,157 | 25 Nov 2025 |
| Caligan Partners LP |
13D/G
3/4/5
13F
Other* · Company
|
10%
|
$43,635,492
6,503,054 shares
|
$0 | 26 Dec 2025 |
| Affinity Asset Advisors, LLC |
13D/G
13F
Company
|
5.5%
|
$7,346,762
884,172 shares
|
$0 | 22 Jan 2026 |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
Company
|
5%
|
$3,649,153
439,657 shares
|
-$1,656,149 | 31 Dec 2025 |
| PERCEPTIVE ADVISORS LLC |
3/4/5
13D/G
10%+ Owner
|
1.6%
from 13D/G
|
$51,398,078
7,099,182 shares
|
— | 27 Dec 2023 |
| BKB Growth Investments, LLC |
3/4/5
10%+ Owner
|
38%
|
$27,822,292
3,348,372 shares
|
— | 25 Nov 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
6
Shares
17,313
Rows available
6
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
39
Q2 2026 holders
6
Holder diff
-33
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend